6-Bicyclopiperazinyl-1-arylsulfonylindoles and 6-bicyclopiperidinyl-1-arylsulfonylindoles derivatives as novel, potent, and selective 5-HT6 receptor antagonists
- Bioorg Med Chem Lett. 2000 Aug 7;10(15):1719-21. doi: 10.1016/s0960-894x(00)00320-6.
- 1. NPS Allelix Corp., Mississauga, ON, Canada. [email protected]
A novel series of 6-bicyclopiperazinyl-1-arylsulfonylindoles and 6-bicyclopiperidinyl-1-arylsulfonylindoles derivatives was synthesized and found to be potent and selective 5-HT6 receptor antagonists.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: 5-HT ReceptorResearch Areas: Neurological Disease
-
target: 5-HT ReceptorResearch Areas: Neurological Disease